- Home
- QTI vs MBIO Comparison
QTI vs MBIO Comparison
Compare QTI & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QTI
- MBIO
- Stock Information
- Founded
- QTI 2012
- MBIO 2015
- Country
- QTI United States
- MBIO United States
- Employees
- QTI N/A
- MBIO N/A
- Industry
- QTI
- MBIO Biotechnology: Pharmaceutical Preparations
- Sector
- QTI
- MBIO Health Care
- Exchange
- QTI NYSE
- MBIO Nasdaq
- Market Cap
- QTI 8.7M
- MBIO 9.1M
- IPO Year
- QTI N/A
- MBIO N/A
- Fundamental
- Price
- QTI $0.42
- MBIO $0.17
- Analyst Decision
- QTI
- MBIO Strong Buy
- Analyst Count
- QTI 0
- MBIO 1
- Target Price
- QTI N/A
- MBIO $2.00
- AVG Volume (30 Days)
- QTI 192.0K
- MBIO 669.7K
- Earning Date
- QTI 11-13-2024
- MBIO 11-08-2024
- Dividend Yield
- QTI N/A
- MBIO N/A
- EPS Growth
- QTI N/A
- MBIO N/A
- EPS
- QTI N/A
- MBIO N/A
- Revenue
- QTI $4,037,118.00
- MBIO N/A
- Revenue This Year
- QTI N/A
- MBIO N/A
- Revenue Next Year
- QTI N/A
- MBIO N/A
- P/E Ratio
- QTI N/A
- MBIO N/A
- Revenue Growth
- QTI 10884.16
- MBIO N/A
- 52 Week Low
- QTI $0.37
- MBIO $0.13
- 52 Week High
- QTI $14.40
- MBIO $1.53
- Technical
- Relative Strength Index (RSI)
- QTI 40.05
- MBIO 33.19
- Support Level
- QTI $0.37
- MBIO $0.15
- Resistance Level
- QTI $0.52
- MBIO $0.21
- Average True Range (ATR)
- QTI 0.05
- MBIO 0.02
- MACD
- QTI -0.01
- MBIO -0.00
- Stochastic Oscillator
- QTI 27.78
- MBIO 25.56
About QTI QT IMAGING HOLDINGS INC
QT Imaging Holdings Inc is engaged in the research, development and commercialization of an automated breast imaging system producing high-resolution transmission ultrasound images.
About MBIO Mustang Bio Inc.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.